The Company argenx SE (United States), is listed on Nasdaq with a market cap of $ 56.05 Billions, having an equity of $ -.
With a total of 336 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.
In the last 12 months the Company had a revenue of $ 3.60 Billions, which generated a profit in the amount of $ 1.53 Billion.
As for its main indicators, the Company has a P/E ratio of 36.56, a P/BV ratio of 0.00 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker ARGX.